Novel Drug Delivery Systems Market Report

Table of Contents

1 Methodology and Scope

• 1.1 Market Segmentation & Scope

• 1.1.1 Technology Type

• 1.1.2 Product

• 1.1.3 Application

• 1.1.4 Regional scope

• 1.1.5 Estimates and forecast timeline

• 1.2 Research Methodology

• 1.3 Information Procurement

• 1.3.1 Purchased database

• 1.3.2 Internal database

• 1.3.3 Secondary sources

• 1.3.4 Primary research

• 1.3.5 Details of primary research

• 1.4 Information or Data Analysis

• 1.4.1 Data analysis models

• 1.5 Market Formulation & Validation

• 1.6 Model Details

• 1.6.1 Commodity flow analysis

• 1.6.2 Volume price analysis

• 1.7 List of Secondary Sources

• 1.8 List of Abbreviations

2 Executive Summary

• 2.1 Market Outlook

• 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook

• 3.1.1 Parent market outlook

• 3.1.2 Ancillary market outlook

• 3.2 Market Segmentation

• 3.2.1 Analysis

• 3.3 Market Dynamics

• 3.3.1 Market driver analysis

• 3.3.2 Market restraint analysis

• 3.3.3 Industry opportunities

• 3.4 Penetration & Growth Prospect Mapping

• 3.4.1 Penetration & growth prospect mapping analysis

• 3.5 Business Environment Analysis Tools

• 3.5.1 Porter's five forces analysis

• 3.5.2 PESTLE analysis

• 3.5.3 Major deals & strategic alliances analysis

4 Novel Drug Delivery Systems Market: Technology Type Analysis

• 4.1 Novel Drug Delivery Systems Technology Type Market Share Analysis, 2018 & 2026

• 4.2 Novel Drug Delivery Systems Technology Type Market: Segment Dashboard

• 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

• 4.3.1 Liposomes

• 4.3.2 PEGylated Proteins & Polypeptides

• 4.3.3 Polymer Nanoparticle

• 4.3.4 Protein–drug Conjugates

• 4.3.5 Others

5 Novel Drug Delivery Systems Market: Product Analysis

• 5.1 Novel Drug Delivery Systems Product Market Share Analysis, 2018 & 2026

• 5.2 Novel Drug Delivery Systems Product Market: Segment Dashboard

• 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Novel Drug Delivery Systems Market: Application Analysis

• 6.1 Novel Drug Delivery Systems Application Market Share Analysis, 2018 & 2026

• 6.2 Novel Drug Delivery Systems Application Market: Segment Dashboard

• 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

• 6.3.1 Hospitals & Clinic

• 6.3.2 Cancer Treatment Centers

• 6.3.3 Others

7 Novel Drug Delivery Systems Market: Regional Analysis

• 7.1 Novel Drug Delivery Systems Regional Market Share Analysis, 2018 & 2026

• 7.2 Novel Drug Delivery Systems Regional Market: Segment Dashboard

• 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

• 7.4 List of Players at Regional Level

• 7.4.1 North America

• 7.4.2 Europe

• 7.4.3 Asia Pacific

• 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

• 7.5.1 North America

• 7.5.2 Europe

• 7.5.3 Asia Pacific

• 7.5.4 Latin America

• 7.5.5 MEA

• 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

• 7.6.1 North America

• 7.6.2 Europe

• 7.6.3 Asia Pacific

• 7.6.4 Latin America

• 7.6.5 Middle East & Africa

8 Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, by Key Market Participants

• 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

• 8.3 Vendor Landscape

• 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

• 9.1 Samyang Biopharmaceuticals

• 9.1.1 Samyang Biopharmaceuticals Company Profile and Recent Development

• 9.1.2 Market Performance

• 9.1.3 Product and Service Introduction

• 9.2 Bausch&Lomb

• 9.2.1 Bausch&Lomb Company Profile and Recent Development

• 9.2.2 Market Performance

• 9.2.3 Product and Service Introduction

• 9.3 AbbVie

• 9.3.1 AbbVie Company Profile and Recent Development

• 9.3.2 Market Performance

• 9.3.3 Product and Service Introduction

• 9.4 Astellas

• 9.4.1 Astellas Company Profile and Recent Development

• 9.4.2 Market Performance

• 9.4.3 Product and Service Introduction

• 9.5 TWi Pharmaceuticals

• 9.5.1 TWi Pharmaceuticals Company Profile and Recent Development

• 9.5.2 Market Performance

• 9.5.3 Product and Service Introduction

• 9.6 Pfizer

• 9.6.1 Pfizer Company Profile and Recent Development

• 9.6.2 Market Performance

• 9.6.3 Product and Service Introduction

• 9.7 Aspen

• 9.7.1 Aspen Company Profile and Recent Development

• 9.7.2 Market Performance

• 9.7.3 Product and Service Introduction

• 9.8 Merck

• 9.8.1 Merck Company Profile and Recent Development

• 9.8.2 Market Performance

• 9.8.3 Product and Service Introduction

• 9.9 AstraZeneca

• 9.9.1 AstraZeneca Company Profile and Recent Development

• 9.9.2 Market Performance

• 9.9.3 Product and Service Introduction

• 9.10 Breckenridge Pharmaceuticals

• 9.10.1 Breckenridge Pharmaceuticals Company Profile and Recent Development

• 9.10.2 Market Performance

• 9.10.3 Product and Service Introduction

• 9.11 Celgene

• 9.11.1 Celgene Company Profile and Recent Development

• 9.11.2 Market Performance

• 9.11.3 Product and Service Introduction

• 9.12 Gilead Sciences

• 9.12.1 Gilead Sciences Company Profile and Recent Development

• 9.12.2 Market Performance

• 9.12.3 Product and Service Introduction

• 9.13 Shire

• 9.13.1 Shire Company Profile and Recent Development

• 9.13.2 Market Performance

• 9.13.3 Product and Service Introduction

• 9.14 TOLMAR

• 9.14.1 TOLMAR Company Profile and Recent Development

• 9.14.2 Market Performance

• 9.14.3 Product and Service Introduction

• 9.15 Sanofi

• 9.15.1 Sanofi Company Profile and Recent Development

• 9.15.2 Market Performance

• 9.15.3 Product and Service Introduction

• 9.16 Roche

• 9.16.1 Roche Company Profile and Recent Development

• 9.16.2 Market Performance

• 9.16.3 Product and Service Introduction

• 9.17 Novartis

• 9.17.1 Novartis Company Profile and Recent Development

• 9.17.2 Market Performance

• 9.17.3 Product and Service Introduction

• 9.18 Galen

• 9.18.1 Galen Company Profile and Recent Development

• 9.18.2 Market Performance

• 9.18.3 Product and Service Introduction

• 9.19 Amgen

• 9.19.1 Amgen Company Profile and Recent Development

• 9.19.2 Market Performance

• 9.19.3 Product and Service Introduction

• 9.20 UCB?(Union Chimique Belge)

• 9.20.1 UCB?(Union Chimique Belge) Company Profile and Recent Development

• 9.20.2 Market Performance

• 9.20.3 Product and Service Introduction

• 9.21 Teva

• 9.21.1 Teva Company Profile and Recent Development

• 9.21.2 Market Performance

• 9.21.3 Product and Service Introduction

• 9.22 Johnson & Johnson

• 9.22.1 Johnson & Johnson Company Profile and Recent Development

• 9.22.2 Market Performance

• 9.22.3 Product and Service Introduction

• 9.23 Takeda

• 9.23.1 Takeda Company Profile and Recent Development

• 9.23.2 Market Performance

• 9.23.3 Product and Service Introduction

• 9.24 Dr Reddy

• 9.24.1 Dr Reddy Company Profile and Recent Development

• 9.24.2 Market Performance

• 9.24.3 Product and Service Introduction

• 9.25 AMAG?Pharmaceuticals

• 9.25.1 AMAG?Pharmaceuticals Company Profile and Recent Development

• 9.25.2 Market Performance

• 9.25.3 Product and Service Introduction

The List of Tables and Figures (Totals 99 Figures and 161 Tables)

• Figure Market Size and Growth Rate of Liposomes

• Figure Market Size and Growth Rate of PEGylated Proteins & Polypeptides

• Figure Market Size and Growth Rate of Polymer Nanoparticle

• Figure Market Size and Growth Rate of Protein–drug Conjugates

• Figure Market Size and Growth Rate of Others

• Figure Market Size and Growth Rate of Hospitals & Clinic

• Figure Market Size and Growth Rate of Cancer Treatment Centers

• Figure Market Size and Growth Rate of Others

• Table List of players in North America

• Table List of players in Europe

• Table List of players in Asia Pacific

• Table SWOT analysis

• Table North America Novel Drug Delivery Systems market, by country, 2015 - 2026 (USD Million)

• Table North America Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table North America Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table North America Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table U.S. Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table U.S. Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table U.S. Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Canada Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Canada Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Canada Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Europe Novel Drug Delivery Systems market, by country, 2015 - 2026 (USD Million)

• Table Europe Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Europe Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Europe Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table U.K. Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table U.K. Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table U.K. Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Germany Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Germany Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Germany Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table France Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table France Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table France Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Italy Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Italy Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Italy Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Spain Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Spain Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Spain Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Asia Pacific Novel Drug Delivery Systems market, by country, 2015 - 2026 (USD Million)

• Table Asia Pacific Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Asia Pacific Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Asia Pacific Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table China Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table China Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table China Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Japan Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Japan Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Japan Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table India Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table India Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table India Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Latin America Novel Drug Delivery Systems market, by country, 2015 - 2026 (USD Million)

• Table Latin America Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Latin America Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Latin America Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Brazil Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Brazil Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Brazil Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Mexico Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Mexico Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Mexico Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Argentina Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Argentina Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Argentina Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table MEA Novel Drug Delivery Systems market, by country, 2015 - 2026 (USD Million)

• Table MEA Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table MEA Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table MEA Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table South Africa Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table South Africa Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table South Africa Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Nigeria Novel Drug Delivery Systems market, by type, 2015 - 2026 (USD Million)

• Table Nigeria Novel Drug Delivery Systems market, by product, 2015 - 2026 (USD Million)

• Table Nigeria Novel Drug Delivery Systems market, by application, 2015 - 2026 (USD Million)

• Table Recent Developments & Impact Analysis, by Key Market Participants

• Table Recent Developments & Impact Analysis, by Key Market Participants

• Table Company market position analysis

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samyang Biopharmaceuticals

• Figure Sales and Growth Rate Analysis of Samyang Biopharmaceuticals

• Figure Revenue and Market Share Analysis of Samyang Biopharmaceuticals

• Table Product and Service Introduction of Samyang Biopharmaceuticals

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bausch&Lomb

• Figure Sales and Growth Rate Analysis of Bausch&Lomb

• Figure Revenue and Market Share Analysis of Bausch&Lomb

• Table Product and Service Introduction of Bausch&Lomb

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

• Figure Sales and Growth Rate Analysis of AbbVie

• Figure Revenue and Market Share Analysis of AbbVie

• Table Product and Service Introduction of AbbVie

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

• Figure Sales and Growth Rate Analysis of Astellas

• Figure Revenue and Market Share Analysis of Astellas

• Table Product and Service Introduction of Astellas

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of TWi Pharmaceuticals

• Figure Sales and Growth Rate Analysis of TWi Pharmaceuticals

• Figure Revenue and Market Share Analysis of TWi Pharmaceuticals

• Table Product and Service Introduction of TWi Pharmaceuticals

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

• Figure Sales and Growth Rate Analysis of Pfizer

• Figure Revenue and Market Share Analysis of Pfizer

• Table Product and Service Introduction of Pfizer

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen

• Figure Sales and Growth Rate Analysis of Aspen

• Figure Revenue and Market Share Analysis of Aspen

• Table Product and Service Introduction of Aspen

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

• Figure Sales and Growth Rate Analysis of Merck

• Figure Revenue and Market Share Analysis of Merck

• Table Product and Service Introduction of Merck

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

• Figure Sales and Growth Rate Analysis of AstraZeneca

• Figure Revenue and Market Share Analysis of AstraZeneca

• Table Product and Service Introduction of AstraZeneca

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Breckenridge Pharmaceuticals

• Figure Sales and Growth Rate Analysis of Breckenridge Pharmaceuticals

• Figure Revenue and Market Share Analysis of Breckenridge Pharmaceuticals

• Table Product and Service Introduction of Breckenridge Pharmaceuticals

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene

• Figure Sales and Growth Rate Analysis of Celgene

• Figure Revenue and Market Share Analysis of Celgene

• Table Product and Service Introduction of Celgene

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences

• Figure Sales and Growth Rate Analysis of Gilead Sciences

• Figure Revenue and Market Share Analysis of Gilead Sciences

• Table Product and Service Introduction of Gilead Sciences

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire

• Figure Sales and Growth Rate Analysis of Shire

• Figure Revenue and Market Share Analysis of Shire

• Table Product and Service Introduction of Shire

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of TOLMAR

• Figure Sales and Growth Rate Analysis of TOLMAR

• Figure Revenue and Market Share Analysis of TOLMAR

• Table Product and Service Introduction of TOLMAR

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

• Figure Sales and Growth Rate Analysis of Sanofi

• Figure Revenue and Market Share Analysis of Sanofi

• Table Product and Service Introduction of Sanofi

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

• Figure Sales and Growth Rate Analysis of Roche

• Figure Revenue and Market Share Analysis of Roche

• Table Product and Service Introduction of Roche

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

• Figure Sales and Growth Rate Analysis of Novartis

• Figure Revenue and Market Share Analysis of Novartis

• Table Product and Service Introduction of Novartis

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galen

• Figure Sales and Growth Rate Analysis of Galen

• Figure Revenue and Market Share Analysis of Galen

• Table Product and Service Introduction of Galen

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

• Figure Sales and Growth Rate Analysis of Amgen

• Figure Revenue and Market Share Analysis of Amgen

• Table Product and Service Introduction of Amgen

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB?(Union Chimique Belge)

• Figure Sales and Growth Rate Analysis of UCB?(Union Chimique Belge)

• Figure Revenue and Market Share Analysis of UCB?(Union Chimique Belge)

• Table Product and Service Introduction of UCB?(Union Chimique Belge)

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

• Figure Sales and Growth Rate Analysis of Teva

• Figure Revenue and Market Share Analysis of Teva

• Table Product and Service Introduction of Teva

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

• Figure Sales and Growth Rate Analysis of Johnson & Johnson

• Figure Revenue and Market Share Analysis of Johnson & Johnson

• Table Product and Service Introduction of Johnson & Johnson

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

• Figure Sales and Growth Rate Analysis of Takeda

• Figure Revenue and Market Share Analysis of Takeda

• Table Product and Service Introduction of Takeda

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy

• Figure Sales and Growth Rate Analysis of Dr Reddy

• Figure Revenue and Market Share Analysis of Dr Reddy

• Table Product and Service Introduction of Dr Reddy

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of AMAG?Pharmaceuticals

• Figure Sales and Growth Rate Analysis of AMAG?Pharmaceuticals

• Figure Revenue and Market Share Analysis of AMAG?Pharmaceuticals

• Table Product and Service Introduction of AMAG?Pharmaceuticals